Affiliation: University of Hawaii
- Consensus Report of the 2015 Weinman International Conference on MesotheliomaMichele Carbone
Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, Hawaii Electronic address
J Thorac Oncol 11:1246-62. 2016....
- Evaluation of clonal origin of malignant mesotheliomaSabahattin Comertpay
University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA
J Transl Med 12:301. 2014....
- BAP1 and cancerMichele Carbone
University of Hawaii Cancer Center, BSB200, 701 Ilalo Street, Honolulu, Hawaii 96813, USA
Nat Rev Cancer 13:153-9. 2013....
- BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsMichele Carbone
University of Hawai i Cancer Center, 677 Ala Moana Boulevard, Suite 901, Honolulu, HI 96813, USA
J Transl Med 10:179. 2012....
- Erionite exposure in North Dakota and Turkish villages with mesotheliomaMichele Carbone
University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96813, USA
Proc Natl Acad Sci U S A 108:13618-23. 2011..Our findings indicate that implementation of novel preventive and early detection programs in ND and other erionite-rich areas of the United States, similar to efforts currently being undertaken in Turkey, is warranted...
- Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammationHaining Yang
Cancer Research Center of Hawaii, John A Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA
Proc Natl Acad Sci U S A 107:12611-6. 2010..Chemopreventive approaches aimed at inhibiting the chronic inflammatory response, and especially blocking HMGB1, may decrease the risk of malignant mesothelioma among asbestos-exposed cohorts...
- Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesotheliomaSandro Jube
University of Hawai i Cancer Center, John A Burns School of Medicine, University of Hawai i, Honolulu, Hawaii 96813, USA
Cancer Res 72:3290-301. 2012....
- Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signalingFang Qi
University of Hawai i Cancer Center, University of Hawai i, Honolulu, Hawaii Department of Molecular Biosciences and Bioengineering, University of Hawai i, Honolulu, Hawaii
Am J Pathol 183:1654-66. 2013..Continuous administration of chrysotile was required for sustained high serum levels of HMGB1. These data support the hypothesis that differences in biopersistence influence the biological activities of these two asbestos fibers...
- CSPG4 as a target of antibody-based immunotherapy for malignant mesotheliomaZeyana Rivera
University of Hawai i Cancer Center, HI, USA
Clin Cancer Res 18:5352-63. 2012..Therefore, we explored CSPG4 as a suitable target for monoclonal antibody (mAb)-based immunotherapy for MM...
- Mesothelioma epidemiology, carcinogenesis, and pathogenesisHaining Yang
Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813, USA
Curr Treat Options Oncol 9:147-57. 2008..It is hoped that the identification of this putative mesothelioma gene will lead to novel mechanistically driven preventive and therapeutic approaches...
- Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicityDavid Larson
a University of Hawai i Cancer Center, University of Hawai i, Honolulu, Hawai i, USA
J Toxicol Environ Health B Crit Rev 19:213-230. 2016..Therefore, palygorskite is not a likely contributor to the MM cases observed in southern Nevada...
- Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesotheliomaMichele Carbone
Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Oncotarget . 2016..Our study indicated that absence of nuclear BAP1 stain helps differentiate MM from lung carcinomas. We suggest that BAP1 staining should be added to the IHC panel that is currently used to distinguish these malignancies...
- High Incidence of Somatic BAP1 alterations in sporadic malignant mesotheliomaMasaki Nasu
University of Hawai i Cancer Center, University of Hawai i, Honolulu, Hawaii Hamon Center for Therapeutic Oncology Research and Department of Pathology, UT Southwestern Medical Center, Dallas, Texas Department of Biomedical Sciences and Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, California Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania and Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, New York
J Thorac Oncol 10:565-76. 2015..However, the reported frequency of somatic BAP1 mutations in MM varies considerably, a discrepancy that appeared related to either methodological or ethnical differences across various studies...
- Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survivalFrancine Baumann
University of Hawaii Cancer Center, Honolulu, HI 96813, USA
Carcinogenesis 36:76-81. 2015..Appropriate genetic counseling and clinical management should be considered for MM patients who are also BAP1 mutation carriers...
- The relationship between simian virus 40 and mesotheliomaZeyana Rivera
Cancer Research Center of Hawaii and Department of Pathology, University of Hawaii, Honolulu, Hawaii, USA
Curr Opin Pulm Med 14:316-21. 2008..Simian virus 40 is present in some human malignant mesotheliomas. The evidence in favor and against a pathogenic role of simian virus 40 in malignant mesothelioma is discussed in this review...
- A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomesMichele Carbone
Cancer Research Center of Hawaii, Thoracic Oncology Program, Honolulu, Hawaii 96816, USA
Nat Rev Cancer 7:147-54. 2007....
- Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft GrowthMasaki Nasu
University of Hawai i Cancer Center, University of Hawai i at Manoa, Honolulu, HI, USA
Genes Cancer 2:576-84. 2011..It is hoped that this information will also facilitate the identification of those patients who are more likely to benefit from this drug and will also open a new frontier for the use of this drug in tumor types other than MM...
- Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular OncogenesLei Zhang
University of Hawai i Cancer Center, Honolulu, HI, USA
Genes Cancer 1:1008-20. 2010..Our results provide a biological rationale to the observation that 1ESV40 is prevalently detected in brain tumors and wtSV40 in mesotheliomas...
- Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone
Thoracic Oncology Program, University of Hawai i Cancer Center, Honolulu, Hawai i, United States of America
PLoS Genet 11:e1005633. 2015..We have also implemented early-detection strategies that help identify cancers at early-stage, when they can be cured (melanomas) or are more susceptible to therapy (MM and other malignancies). ..
- Fowlpox-based survivin vaccination for malignant mesothelioma therapyPietro Bertino
Department of Cell and Molecular Biology, John A Burns School of Medicine, University of Hawai i, Honolulu, HI 96813, USA
Int J Cancer 133:612-23. 2013..Our results demonstrate that vaccination with recombinant Fowlpox expressing survivin improves T-cell responses against aggressive MM tumors and may form the basis for promising clinical applications...
- Simian virus 40 transformation, malignant mesothelioma and brain tumorsFang Qi
University of Hawaii Cancer Center, Honolulu, HI, USA
Expert Rev Respir Med 5:683-97. 2011..However, it seems possible that SV40 may act as a cofactor in the pathogenesis of some tumors. In vitro and animal experiments showing cocarcinogenicity between SV40 and asbestos support this hypothesis...
- Chemotherapy of malignant pleural mesotheliomaPietro Bertino
Cancer Research Center of Hawaii and Department of Pathology, University of Hawaii, 651 Ilalo Street, BSB Room 231, Honolulu, HI 96813, USA
Expert Opin Pharmacother 10:99-107. 2009..Although the outcome for patients remains poor, there has been definite progress in the systemic treatment of this disease within the past 5 years...
- HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma PatientsAndrea Napolitano
University of Hawaii Cancer Center, Honolulu, Hawaii Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, Hawaii
Clin Cancer Res 22:3087-96. 2016..To determine whether serum levels of high mobility group box protein 1 (HMGB1) could differentiate malignant mesothelioma patients, asbestos-exposed individuals, and unexposed controls...
- Preclinical development of HIvax: Human survivin highly immunogenic vaccinesPeter R Hoffmann
a Department of Cell and Molecular Biology John A Burns School of Medicine University of Hawai i Honolulu, HI, USA
Hum Vaccin Immunother 11:1585-95. 2015..These results provide a rationale for clinical testing of HIvax1 and HIvax2 vaccines in patients with survivin-expressing cancers. ..
- Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesotheliomaMichele Carbone
University of Hawaii Cancer Center, John A Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
Clin Cancer Res 18:598-604. 2012..The very recent discovery that germline BAP1 mutations cause a new cancer syndrome characterized by mesothelioma, uveal melanoma, and melanocytic tumors provides researchers with a novel target for prevention and early detection...
- Malignant mesothelioma: facts, myths, and hypothesesMichele Carbone
University of Hawaii Cancer Center, University of Hawaii, Honolulu, Hawaii 96813, USA
J Cell Physiol 227:44-58. 2012..Genetic predisposition, radiation exposure and viral infection are co-factors that can alone or together with asbestos and erionite cause MM. J. Cell. Physiol. 227: 44-58, 2012. © 2011 Wiley Periodicals, Inc...
- The pathogenesis of mesotheliomaMichele Carbone
Thoracic Oncology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA
Semin Diagn Pathol 23:56-60. 2006..Moreover, these data provide a rationale for the observation that only a fraction of heavily exposed asbestos workers developed mesothelioma, and novel targets for prevention and therapy...
- Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesAngela Bononi
a 1 University of Hawai i Cancer Center, University of Hawai i at Manoa, Honolulu, Hawai i, USA
Expert Rev Respir Med 9:633-54. 2015..We elaborate on the rationale behind new therapeutic strategies, and summarize available preclinical and clinical results, as well as efforts still ongoing. ..
- A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cellsMichele Carbone
Thoracic Oncology Program, Cancer Center of Hawaii and Department of Pathology, University of Hawaii Medical School, Honolulu, Hawaii 96813, USA
Cancer Res 68:9488-96. 2008..Our results reveal a novel biological mechanism responsible for the suppression of late viral gene products, an important step in viral carcinogenesis in humans...
- Gene expression profiles predict survival and progression of pleural mesotheliomaHarvey I Pass
Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
Clin Cancer Res 10:849-59. 2004..We hypothesized that gene expression profiles could predict time to progression and survival in surgically cytoreduced pleural mesothelioma of all stages...
- The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern NevadaFrancine Baumann
Cancer Center, University of Hawaii, Honolulu, Hawaii Department of Geoscience, University of Nevada Las Vegas, Las Vegas, Nevada Department of Environmental, Geographical and Geological Sciences, Bloomsburg University of Pennsylvania, Pennsylvania and USDA, Natural Resources Conservation Service, Las Vegas, Nevada
J Thorac Oncol 10:731-7. 2015....